Lineage Cell Therapeutics (LCTX) Inventory Average (2011 - 2015)
Lineage Cell Therapeutics' (LCTX) quarterly Inventory Average came in at $130500.0 in Q4 2015, down 49.77% year-on-year from $259783.5 in Q4 2014, and down 53.14% quarter-over-quarter from $278500.0 in Q3 2015.
Lineage Cell Therapeutics (LCTX) Inventory Average (2011 - 2015) Analysis & Trends
Lineage Cell Therapeutics' Inventory Average history runs 5 years deep, the most recent figure standing at $130500.0 for Q4 2015.
- On a quarterly basis, Inventory Average fell 49.77% year-over-year to $130500.0 in Q4 2015; TTM through Dec 2015 was $130500.0, a 49.77% decrease from a year earlier, with the FY2015 full-year figure at $133500.0, down 39.96% from the prior year.
- Inventory Average eased to $130500.0 in Q4 2015 per LCTX's latest filing, from $278500.0 in the prior quarter.
- Across five years, Inventory Average topped out at $298154.0 in Q2 2015 and bottomed at $53020.0 in Q1 2012.
- The 5-year median for Inventory Average is $91425.8 (2013), against an average of $143926.5.
- Across the five-year window, Inventory Average soared 322.38% in 2014 and plunged 49.77% in 2015, its largest moves.
- Year by year, Inventory Average stood at $56144.5 in 2011, then fell by 0.0% to $56142.0 in 2012, then soared by 113.59% to $119913.0 in 2013, then soared by 116.64% to $259783.5 in 2014, then tumbled by 49.77% to $130500.0 in 2015.
- Per Business Quant, the three latest LCTX Inventory Average figures stand at $130500.0 (Q4 2015), $278500.0 (Q3 2015), and $298154.0 (Q2 2015).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 644.91 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.15 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Lineage Cell Therapeutics | 267.08 Mn | 203.18 Mn | 1.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 130,500.00 |
| Sep 30, 2015 | 278,500.00 |
| Jun 30, 2015 | 298,154.00 |
| Mar 31, 2015 | 282,654.00 |
| Dec 31, 2014 | 259,783.50 |
| Sep 30, 2014 | 255,748.00 |
| Jun 30, 2014 | 247,258.50 |
| Mar 31, 2014 | 207,641.00 |
| Dec 31, 2013 | 119,913.00 |
| Sep 30, 2013 | 62,938.50 |
| Jun 30, 2013 | 58,540.00 |
| Mar 31, 2013 | 53,825.50 |
| Dec 31, 2012 | 56,142.00 |
| Sep 30, 2012 | 55,993.00 |
| Jun 30, 2012 | 54,942.00 |
| Mar 31, 2012 | 53,020.00 |
| Dec 31, 2011 | 56,144.50 |
| Sep 30, 2011 | 58,979.00 |